ous
ablation is unfortunately difÔ¨Åcult due to the very low
number of events and limited statistical power. Although
inconsistent across studies, suggested risk factors for
EHIT/DVT have included age, male gender, CEAP class,
personal or family history of VTE, known thrombophilia,
reduced mobility, obesity, hormone therapy, active cancer, concomitant procedures including sclerotherapy
and microphlebectomy, large GSV diameter, and a history of